Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/02/09
Mitchell D – A single 15–microgram dose of a nonadjuvanted vaccine against 2009 H1N1 influenza generated a robust immune response in 76 percent of 10– to 17–year–olds eight to 10 days after immunization. A high percentage of adults ages 18 to 64 years had a robust immune response to a single 15–microgram dose of nonadjuvanted vaccine. The vaccines used in the adult clinical trials were manufactured by CSL Ltd., based in Melbourne, Australia, and Sanofi Pasteur Inc., (2–page PDF; About PDFs) based in Swiftwater, Pa. Similar results seen with Sanofi Pasteur's H1N1 vaccine for children ages 10 to 17 years represented good news in terms of vaccine supply and efficacy. Results were not as favorable, however, in younger children. A strong immune response was reported in 36 percent of kids 3 years to 9 years of age who received single 15–microgram dose of the H1N1 vaccine and in only 25 percent of children 6 months to 35 months old who received one such dose. Immune response likely would increase in all age groups closer to 21 days after vaccination. Children ages 6 months to 9 years likely will need two H1N1 doses 21 days apart. Healthy children ages 2 and older can receive live attenuated influenza vaccine, or LAIV, as a nasal spray. Inactivated seasonal flu vaccine and inactivated H1N1 vaccine likely can be administered on the same day via injections in different arms.
Related Articles
Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 99%
H1N1 vaccine shortage leaves doctors managing crowds, anxieties
American Medical News, 11/06/09
Relevance Score: 98%
H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09
Relevance Score: 98%
Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009
Annals of Internal Medicine, 10/09/09
Relevance Score: 98%
H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09
Relevance Score: 98%
Today in Adolescent Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Measuring Alcohol-Related Consequences in School Surveys: Alcohol-Attributable Consequences or Consequences With Students’ Alcohol Attribution
American Journal of Epidemiology, 12/08/09
Dietary intake of trans fatty acids as a cardiovascular risk factor in a population of Italian teenagers
Cardiology in the Young, 12/08/09
Health-Related Quality of Life in Adolescents and Young Adults with a History of Kawasaki Disease
The Journal of Pediatrics, 12/08/09
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting Success in the Endoscopic Management of Pediatric Vesicoureteral Reflux
Urology, 12/08/09
A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections
Journal of Perinatology, 12/08/09
A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines
Journal of Perinatology, 12/08/09
Today in Preventive/Nutrition...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of micronutrients in pregnancy
Australian Family Physician, 12/08/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/08/09
New psycho-pedagogic approach to obesity treatment: A 5-year follow-up
Patient Education and Counselling, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


